{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:52:08Z","timestamp":1791492728881,"version":"4.3.4"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["91949105"],"award-info":[{"award-number":["91949105"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071516"],"award-info":[{"award-number":["82071516"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31501864"],"award-info":[{"award-number":["31501864"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81771227"],"award-info":[{"award-number":["81771227"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["GK201603118"],"award-info":[{"award-number":["GK201603118"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017596","name":"Natural Science Basic Research Program of Shaanxi Province","doi-asserted-by":"publisher","award":["2023-JC-YB-189"],"award-info":[{"award-number":["2023-JC-YB-189"]}],"id":[{"id":"10.13039\/501100017596","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013804","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013804","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.neuropharm.2026.110926","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T23:43:39Z","timestamp":1773272619000},"page":"110926","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Glutamatergic cannabinoid receptor 1 confers neuroprotection against ischemic stroke by suppressing excitotoxicity and anoxic depolarization"],"prefix":"10.1016","volume":"291","author":[{"given":"Yitong","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingqing","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Congpeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningning","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanting","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Congbei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanning","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2026.110926_bib1","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1126\/science.1072873","article-title":"Treatment of ischemic brain damage by perturbing NMDA receptor- PSD-95 protein interactions","volume":"298","author":"Aarts","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2026.110926_bib2","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1161\/STROKEAHA.121.034131","article-title":"Endocannabinoid response in acute ischemic stroke: elevated 2-Arachidonoylglycerol","volume":"52","author":"Buciuc","year":"2021","journal-title":"Stroke"},{"key":"10.1016\/j.neuropharm.2026.110926_bib3","doi-asserted-by":"crossref","first-page":"824093","DOI":"10.1155\/2012\/824093","article-title":"Update on the role of cannabinoid receptors after ischemic stroke","volume":"2012","author":"Capettini","year":"2012","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.neuropharm.2026.110926_bib4","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1161\/hs1101.098367","article-title":"Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats","volume":"32","author":"Chen","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.neuropharm.2026.110926_bib5","doi-asserted-by":"crossref","first-page":"8257","DOI":"10.1073\/pnas.1400988111","article-title":"A restricted population of CB1 cannabinoid receptors with neuroprotective activity","volume":"111","author":"Chiarlone","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2026.110926_bib6","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1469-7793.2000.00143.x","article-title":"Direct measurement of adenosine release during hypoxia in the CA1 region of the rat hippocampal slice","volume":"526","author":"Dale","year":"2000","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuropharm.2026.110926_bib7","first-page":"e2423","article-title":"Modeling stroke in mice - middle cerebral artery occlusion with the filament model","volume":"47","author":"Engel","year":"2011","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.neuropharm.2026.110926_bib8","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1177\/17474930211065917","article-title":"World Stroke Organization (WSO): global stroke fact sheet 2022","volume":"17","author":"Feigin","year":"2022","journal-title":"Int. J. Stroke"},{"key":"10.1016\/j.neuropharm.2026.110926_bib9","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S0028-3908(97)00084-1","article-title":"The effects of metabolic stress on glutamate receptor-mediated depolarizations in the in vitro rat hippocampal slice","volume":"36","author":"Frenguelli","year":"1997","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.110926_bib10","article-title":"Endocannabinoids inhibit contextual fear memory generalization via hippocampal GABAergic synaptic transmission","volume":"122","author":"Ge","year":"2025"},{"key":"10.1016\/j.neuropharm.2026.110926_bib11","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nrn2911","article-title":"Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders","volume":"11","author":"Hardingham","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110926_bib12","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0140-6736(20)30258-0","article-title":"Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial","volume":"395","author":"Hill","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2026.110926_bib13","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.neuropharm.2004.12.012","article-title":"Accumulation of anandamide: evidence for cellular diversity","volume":"48","author":"Hillard","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.110926_bib14","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.neuroscience.2016.10.067","article-title":"Differential spread of anoxic depolarization contributes to the pattern of neuronal injury after oxygen and glucose deprivation (OGD) in the substantia nigra in rat brain slices","volume":"340","author":"Karunasinghe","year":"2017","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2026.110926_bib15","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1124\/mol.105.016428","article-title":"Molecular mechanisms of cannabinoid protection from neuronal excitotoxicity","volume":"69","author":"Kim","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.110926_bib16","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1523\/JNEUROSCI.4232-04.2005","article-title":"Involvement of cannabinoid receptors in the regulation of neurotransmitter release in the rodent striatum: a combined immunochemical and pharmacological analysis","volume":"25","author":"K\u00f6falvi","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110926_bib17","first-page":"1","article-title":"The endocannabinoid system and stroke: a focused review","volume":"5","author":"Kolb","year":"2019","journal-title":"Brain Circ."},{"key":"10.1016\/j.neuropharm.2026.110926_bib18","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0896-6273(01)00246-X","article-title":"Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto purkinje cells","volume":"29","author":"Kreitzer","year":"2001","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2026.110926_bib19","doi-asserted-by":"crossref","first-page":"20270","DOI":"10.1073\/pnas.0909411106","article-title":"Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo","volume":"106","author":"Long","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2026.110926_bib20","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/j.bcp.2004.07.007","article-title":"On-demand activation of the endocannabinoid system in the control of neuronal excitability and epileptiform seizures","volume":"68","author":"Lutz","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.110926_bib21","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nmeth.2333","article-title":"An optimized fluorescent probe for visualizing glutamate neurotransmission","volume":"10","author":"Marvin","year":"2013","journal-title":"Nat. Methods"},{"key":"10.1016\/j.neuropharm.2026.110926_bib22","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1523\/JNEUROSCI.4503-03.2004","article-title":"Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors","volume":"24","author":"Melis","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110926_bib23","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1523\/JNEUROSCI.19-08-02987.1999","article-title":"Cannabinoids and neuroprotection in global and focal cerebral ischemia and in neuronal cultures","volume":"19","author":"Nagayama","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110926_bib24","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0896-6273(01)00247-1","article-title":"Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals","volume":"29","author":"Ohno-Shosaku","year":"2001","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2026.110926_bib25","doi-asserted-by":"crossref","first-page":"9771","DOI":"10.1523\/JNEUROSCI.22-22-09771.2002","article-title":"Increased severity of stroke in CB1 cannabinoid receptor knock-out mice","volume":"22","author":"Parmentier Batteur","year":"2002","journal-title":"J. Neurosci. : Off. J. Soc. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110926_bib26","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.neuron.2014.03.030","article-title":"Extrasynaptic NMDA receptor involvement in central nervous system disorders","volume":"82","author":"Parsons","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2026.110926_bib27","first-page":"552","article-title":"Vanilloid VR1 receptor is involved in rimonabant-induced neuroprotection","volume":"147","author":"Pegorini","year":"2006"},{"key":"10.1016\/j.neuropharm.2026.110926_bib28","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0079-6123(08)61973-1","article-title":"Selective neuronal vulnerability: morphological and molecular characteristics","volume":"63","author":"Pulsinelli","year":"1985","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.neuropharm.2026.110926_bib29","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.neuron.2009.06.021","article-title":"Activity-dependent regulation of synapses by retrograde messengers","volume":"63","author":"Regehr","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2026.110926_bib30","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/2040-7378-2-13","article-title":"Functional assessments in the rodent stroke model","volume":"2","author":"Schaar","year":"2010","journal-title":"Exp. Transl. Stroke Med."},{"key":"10.1016\/j.neuropharm.2026.110926_bib31","doi-asserted-by":"crossref","first-page":"5080","DOI":"10.1093\/nar\/23.24.5080","article-title":"A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells","volume":"23","author":"Schwenk","year":"1995","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.neuropharm.2026.110926_bib32","doi-asserted-by":"crossref","first-page":"4322","DOI":"10.1523\/JNEUROSCI.16-14-04322.1996","article-title":"Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures","volume":"16","author":"Shen","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110926_bib33","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1111\/j.1476-5381.2011.01343.x","article-title":"Endocannabinoids and traumatic brain injury","volume":"163","author":"Shohami","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.110926_bib34","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1177\/0271678X18755661","article-title":"Long-term depression induced by endogenous cannabinoids produces neuroprotection via astroglial CB1R after stroke in rodents","volume":"39","author":"Wang","year":"2019","journal-title":"J. Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.neuropharm.2026.110926_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.mvr.2021.104263","article-title":"Impaired vessel relaxation response and increased infarct size in smooth muscle cannabinoid receptor 1 knockout mice","volume":"139","author":"Wang","year":"2022","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.neuropharm.2026.110926_bib36","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0014-2999(03)01734-5","article-title":"Cannabinoid CB1 receptor-mediated inhibition of glutamate release from rat hippocampal synaptosomes","volume":"469","author":"Wang","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.110926_bib37","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/mp.2016.22","article-title":"Monoacylglycerol lipase inhibitors produce pro- or antidepressant responses via hippocampal CA1 GABAergic synapses","volume":"22","author":"Wang","year":"2017","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2026.110926_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lfs.2017.12.030","article-title":"Surprising outcomes in cannabinoid CB1\/CB2 receptor double knockout mice in two models of ischemia","volume":"195","author":"Ward","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2026.110926_bib39","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/aps.2012.95","article-title":"Ionotropic receptors and ion channels in ischemic neuronal death and dysfunction","volume":"34","author":"Weilinger","year":"2013","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.neuropharm.2026.110926_bib40","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/35069076","article-title":"Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses","volume":"410","author":"Wilson","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2026.110926_bib41","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1177\/0271678X21994395","article-title":"Activation of astroglial CB1R mediates cerebral ischemic tolerance induced by electroacupuncture","volume":"41","author":"Yang","year":"2021","journal-title":"J. Cerebr. Blood Flow Metabol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826000997?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826000997?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T02:32:33Z","timestamp":1776133953000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390826000997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":41,"alternative-id":["S0028390826000997"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.110926","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glutamatergic cannabinoid receptor 1 confers neuroprotection against ischemic stroke by suppressing excitotoxicity and anoxic depolarization","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.110926","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110926"}}